Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Terminated
2(22%)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_1
1
11%
Ph phase_2
1
11%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(6)
Terminated(2)
Other(1)

Detailed Status

Completed6
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
N/A3 (60.0%)

Trials by Status

unknown111%
terminated222%
completed667%

Recent Activity

0 active trials
Showing 5 of 9
completed

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

NCT03091816
completed

The Influence of Coronary Chronic Total Occlusion on Myocardial Perfusion on Computed Tomography

NCT04465526
terminatednot_applicable

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

NCT03412630
completedphase_1

CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy

NCT02693080
completed

Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors

NCT02960308
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT03091816

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

Completed
NCT04465526

The Influence of Coronary Chronic Total Occlusion on Myocardial Perfusion on Computed Tomography

Completed
NCT03412630Not Applicable

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Terminated
NCT02693080Phase 1

CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy

Completed
NCT02960308

Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors

Completed
NCT03990623Not Applicable

CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization

Unknown
NCT01387113

The PERFusion Use in Stroke Evaluation Study

Completed
NCT03012282Not Applicable

CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer

Terminated
NCT02101918Phase 2

Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery

Completed

All 9 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
9